Page 2,510«..1020..2,5092,5102,5112,512..2,5202,530..»

Stem Cell 101: Mayo Clinic Expert Answers Commonly Asked Questions

Posted: November 29, 2012 at 6:40 pm

Released: 11/28/2012 3:45 PM EST Source: Mayo Clinic Expert Available

Newswise ROCHESTER, Minn. -- Next week, more than 1,200 people from 25 countries are expected to attend the 8th Annual World Stem Cell Summit in West Palm Beach, Fla., a gathering co-sponsored by Mayo Clinic. As those close to the science explore potential stem cell applications, many patients have questions about what stem cells are and how they are being used. Timothy Nelson, M.D., Ph.D., director of Mayo Clinics Regenerative Medicine Consult Service, answers some of the most commonly asked questions about stem cells:

MULTIMEDIA ALERT: Multimedia resources, including a Medical Edge package, are available for journalists to download on the Mayo Clinic News Network.

What are stem cells? Stem cells are the bodys raw materials. These cells have the ability to renew themselves or change to become specialized cells with a more specific function, such as blood cells, brain cells, heart muscle or bone.

Where do stem cells come from? Adult stem cells are found in tissues of the body, such as bone marrow. Emerging evidence suggests that adult stem cells may be more versatile than previously thought and have the ability to create other types of cells. Amniotic fluid stem cells come from the liquid that surrounds a developing fetus in the amniotic sac. More study of amniotic fluid stem cells is needed to understand their potential. Embryonic stem cells are a general stem cell found in embryos. Use of this type of stem cell has significantly declined due to the discovery of induced pluripotent stem cells. Induced pluripotent stem cells, commonly known as iPS cells, are derived from an adult stem cell that behaves like an embryonic stem cell. This new technique may help researchers avoid the controversy that comes with embryonic stem cells and prevent immune system rejection of the new stem cells. Mesenchymal stem cells are adult stem cells found in tissues such as bone marrow, blood and the fallopian tube. They can become bone, cartilage, fat and possibly other cells.

How are stem cells being used to treat diseases? Stem cell transplants, also known as bone marrow transplants, have been performed in the United States since the late 1960s. These transplants use adult stem cells.

Thanks to new technology, researchers are exploring the use of stem cells to treat a range of conditions. For example, teams at Mayo Clinic are investigating the use of adult stem cells to delay or eliminate the need for some hip replacements.

Adult stem cells are being tested to treat degenerative diseases such as heart failure. Stem cells from umbilical cord blood have been successfully used in clinical trials to treat cancer and blood-related diseases.

What does the future hold for stem cell therapy? The use of adult stem cells continues to be refined and improved. Researchers are discovering that these cells may be more versatile than originally thought, which means they may be able to treat a wider variety of diseases, such as diabetes; heart, liver and lung diseases; neurological and bone disorders; hand, face and other injuries; and congenital anomalies.

Dr. Nelson and other Mayo Clinic experts are available to discuss current research and the development of new stem cell therapies.

See the article here:
Stem Cell 101: Mayo Clinic Expert Answers Commonly Asked Questions

Posted in Stem Cell Therapy | Comments Off on Stem Cell 101: Mayo Clinic Expert Answers Commonly Asked Questions

Professors Critique Stem Cell Medical Tourism

Posted: November 29, 2012 at 6:40 pm

A panel at the Harvard Law School Wednesday discussed the ethical debate over the use of embryonic stem cells in the United States, focusing on the burgeoning controversy surrounding the role of stem cell therapy in medical tourism.

Medical tourism, in which patients travel internationally to gain access to specific health care services, has become increasingly common, panelists said. They said that reasons for medical tourism range from basic hip replacement surgery to black market organ sales. As most stem cell therapies are not approved in the United States, numerous patients are going abroad to countries like China and Russia where treatment is legal.

Panelist I. Glenn Cohen, an assistant professor at the Law School, said that it was probable that a Chinese stem cell facility performs several hundred thousand of these treatments yearly. He said that numerous celebrities, including football quarterback Peyton Manning, have reportedly traveled abroad to receive stem cell treatment not approved by the FDA.

A number of facilities claim to use stem cells to cure a wide array of diseases. University of Alberta law professor Timothy Caulfield, another panelist, pointed out that a simple Google search leads potential patients to a plethora of websites which claim that diseases such as autism and cancer can be cured through stem cell therapy.

Its being offered as routine, its being offered as safe, its being offered as effective, Caulfield said, citing his own 2008 study on the subject, Of course, none of them being offered matched what the scientific literature said.

According to American history professor Jill Lepore, the hyper-acceleration of enthusiasm for stem cell therapy is reminiscent of a century ago when science journalism and government funding for science research began to blossom. Lepore pointed out how public excitement over scientific procedures has affected society in the past, popularizing cryonics research and the work of Eugene Steinach, who claimed his vasectomy operation reversed the aging process.

Panelists said that one issue with stem cell tourism is the number of health risks associated with such procedures, citing a number of instances where stem cell therapy caused serious harm.

They also noted that public discussion about stem cell therapy has been markedly positive, lending an air of legitimacy to stem cell therapy that hasnt been validated by research.

Articles criticizing stem cell tourism, on the other hand, have generally received a less favorable response. Caulfield told the audience that when he co-wrote an article in The Atlantic criticizing stem cell therapy, he was accused as being a nutball Canadian socialist bioethicist.

The panelists emphasized that more accurate information should be provided to the public regarding stem cell treatments.

Continued here:
Professors Critique Stem Cell Medical Tourism

Posted in Stem Cell Therapy | Comments Off on Professors Critique Stem Cell Medical Tourism

SCMOM 2012_Cytomedix – Video

Posted: November 28, 2012 at 3:43 pm


SCMOM 2012_Cytomedix
Cytomedix, Inc. (OTCBB:CMXI) is a US-based company that is developing and commercializing autologous regenerative biotherapies that promote healing by harnessing the innate regenerative capacity of platelets and adult stem cells. http://www.cytomedix.com Presenter: Ed Field, COO, CytomedixFrom:AllianceRegenMedViews:4 1ratingsTime:10:32More inScience Technology

See original here:
SCMOM 2012_Cytomedix - Video

Posted in Stem Cell Videos | Comments Off on SCMOM 2012_Cytomedix – Video

SCMOM 2012_Regenerative Patch Technologies – Video

Posted: November 28, 2012 at 3:43 pm


SCMOM 2012_Regenerative Patch Technologies
Regenerative Patch Technologies was formed to advance development of a composite RPE cell-membrane technology currently supported by a disease team award to the University of Southern California, the University of California, Santa Barbara, and the California Institute of Technology from the California Institute of Regenerative Medicine. The technology utilizes polarized RPE cells derived from human embryonic stem cells together with an ultrathin biocompatible parylene membrane as a replacement for the defective Bruch #39;s membrane RPE cell complex often observed in patients with the atrophic form of age related macular degeneration. The project is progressing through preclinical studies to enable IND filing in 2014. http://www.regenerativepatch.com Presenter: Jane Lebkowski, President and CSO, Regenerative Patch TechnologiesFrom:AllianceRegenMedViews:11 1ratingsTime:15:22More inScience Technology

See the rest here:
SCMOM 2012_Regenerative Patch Technologies - Video

Posted in Stem Cell Videos | Comments Off on SCMOM 2012_Regenerative Patch Technologies – Video

SCMOM 2012_Q Therapeutics – Video

Posted: November 28, 2012 at 3:43 pm


SCMOM 2012_Q Therapeutics
Q Therapeutics is harnessing the power of stem cells to treat debilitating diseases of the central nervous system, which encompass a broad range of diseases including ALS, multiple sclerosis, spinal cord injury, stroke, cerebral palsy, Parkinson #39;s and Alzheimer #39;s diseases. Q-Cells function as #39;mini-factories #39; to repair neurons, utilizing multiple pathways including myelination, growth factor production and toxin removal. By utilizing the natural support and repair mechanisms of healthy CNS, safety and efficacy are enhanced. Q has a strong proprietary position with 16 patents issued and 12 pending. Our products address a multi-billion dollar market opportunity for which traditional drugs have failed. http://www.qthera.com Presenter: Deborah Eppstein, Ph.D., President and CEO, Q TherapeuticsFrom:AllianceRegenMedViews:4 1ratingsTime:10:47More inScience Technology

Here is the original post:
SCMOM 2012_Q Therapeutics - Video

Posted in Stem Cell Videos | Comments Off on SCMOM 2012_Q Therapeutics – Video

SCMOM 2012_StemBioSys – Video

Posted: November 28, 2012 at 3:43 pm


SCMOM 2012_StemBioSys
StemBioSys is a development-stage company with novel technologies to isolate and expand specialized stem cell (SC) populations, including large numbers of elusive, pluri-potent, embryonic-like stem cells (ELSCs) from cord blood. The core technology platform is a patented ECM, produced by bone marrow MSCs, which replicates their native microenvironment, promotes proliferation of various SC beyond current methods and preserves SC phenotypes ("stemness"). StemBioSys ELSCs have generated tissues in vivo from all three germ layers, providing a viable research and clinical alternative to both hESCs and iPS cells. These technologies help overcome major obstacles to developing autologous and allogenic stem cell therapies. http://www.stembiosys.com Presenter: Steven Davis, CEO, StemBioSysFrom:AllianceRegenMedViews:3 1ratingsTime:13:08More inScience Technology

Read the rest here:
SCMOM 2012_StemBioSys - Video

Posted in Stem Cell Videos | Comments Off on SCMOM 2012_StemBioSys – Video

Dr. Michael Fehlings – J. Allyn Taylor International Prize in Medicine Symposium 2012 – Video

Posted: November 28, 2012 at 3:43 pm


Dr. Michael Fehlings - J. Allyn Taylor International Prize in Medicine Symposium 2012
Michael Fehlings, MD, PhD, FRCSC, FACS, Professor of Neurosurgery, University of Toronto, Gerald and Tootsie Halbert Chair in Neural Repair and Regeneration, Medical Director, Krembil Neuroscience Center. Stem cells and bioengineered strategies for cervical spinal cord injury.From:WesternUniversityViews:4 0ratingsTime:43:57More inEducation

Read more:
Dr. Michael Fehlings - J. Allyn Taylor International Prize in Medicine Symposium 2012 - Video

Posted in Stem Cell Videos | Comments Off on Dr. Michael Fehlings – J. Allyn Taylor International Prize in Medicine Symposium 2012 – Video

Dr. Wolfram Tetzlaff – J. Allyn Taylor International Prize in Medicine Symposium 2012 – Video

Posted: November 28, 2012 at 3:42 pm


Dr. Wolfram Tetzlaff - J. Allyn Taylor International Prize in Medicine Symposium 2012
Wolfram Tetzlaff, MD, PhD, Professor, Zoology and Surgery, Associate Director ICORD, Man in Motion Chair in Spinal Cord Research. From diets to stem cells: preclinical strategies for spinal cord injury.From:WesternUniversityViews:4 0ratingsTime:47:47More inEducation

Visit link:
Dr. Wolfram Tetzlaff - J. Allyn Taylor International Prize in Medicine Symposium 2012 - Video

Posted in Stem Cell Videos | Comments Off on Dr. Wolfram Tetzlaff – J. Allyn Taylor International Prize in Medicine Symposium 2012 – Video

The Cure: A Documentary on Regenerative Medicine (Part 1) – Video

Posted: November 28, 2012 at 3:42 pm


The Cure: A Documentary on Regenerative Medicine (Part 1)
Filmmaker David Alvarado tells the remarkable, behind-the-scenes story on the founding of the Silicon Valley Institute of Regenerative Medicine. Through a public/private partnership with Santa Clara Valley Medical Center, Stanford University, the County of Santa Clara, the Palo Alto VA and others, the Institute hopes to facilitate major breakthroughs in the treatment of spinal cord and other injuries using stem cells.From:VMCFoundationViews:14 0ratingsTime:07:07More inScience Technology

Here is the original post:
The Cure: A Documentary on Regenerative Medicine (Part 1) - Video

Posted in Stem Cell Videos | Comments Off on The Cure: A Documentary on Regenerative Medicine (Part 1) – Video

First steps to create a new drug targeting cancer stem cells – Video

Posted: November 28, 2012 at 3:42 pm


First steps to create a new drug targeting cancer stem cells
Galina Botchkina, from Stony Brook University, explains the first steps (in vitro testing) that researchers should take to create a new drug that specifically targets cancer stem cells. By Marta Lora. November 2012From:martacharmedViews:7 0ratingsTime:02:02More inScience Technology

More:
First steps to create a new drug targeting cancer stem cells - Video

Posted in Stem Cell Videos | Comments Off on First steps to create a new drug targeting cancer stem cells – Video

Page 2,510«..1020..2,5092,5102,5112,512..2,5202,530..»